For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Lupin Q3 net profits increase to Rs. 476 crore

|
Lupin Q3 net profits increase to Rs. 476 crore
Lupin, a leading pharmaceutical company, reported today higher Q3 net profit at Rs. 476 crore in comparison to Rs. 335 crore in the corresponding period a year ago, an increase of 42%. The revenue of the company grew by 20.8% y-o-y from Rs 2,501 crore to Rs. 3,022 crore in the quarter ended December.
 

EBITDA of the company came in at Rs. 805.7 crore in the quarter while operating margin stood at 25.9%. The better than expected results reported by the pharma major are on the back of strong growth in the US markets.

Nilesh Gupta, Managing Director of the company, was quoted in one of the business dailies saying "Other markets like India are getting back on track also. Our consistent focus on ramping up operational efficiencies has led to higher margins and better profitability,".

GoodReturns.in

Read more about: lupin q3 results net profit ebitda
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more